Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

Although high-dose cisplatin is the standard regimen of concurrent chemoradiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (HNSCC), varying levels of patient tolerance towards cisplatin have been reported, and the predictive factors of cisplatin tolerance remain to be elu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: NAKANO, KENJI, SATO, YASUYOSHI, TOSHIYASU, TAKASHI, SATO, YUKIKO, INAGAKI, LINA, TOMOMATSU, JUNICHI, SASAKI, TORU, SHIMBASHI, WATARU, FUKUSHIMA, HIROFUMI, YONEKAWA, HIROYUKI, MITANI, HIROKI, KAWABATA, KAZUYOSHI, TAKAHASHI, SHUNJI
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734196/
https://ncbi.nlm.nih.gov/pubmed/26893880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.687
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars